Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Five Hemlibra Deaths But Not Caused By Hemophilia Drug – Roche

Mar 28 2018

• By Kevin Grogan

Blood drops — Hemlibra deaths highlight hemophilia A challenges • Source: Shutterstock

Related Content

Hemophilia Community Not 'Choosing A Side' In Hemlibra Litigation

Feb 02 2018

Sanofi Builds Blood Disorder Specialty With Bioverativ Buy

Jan 22 2018

Non-Inhibitor Data Secure Roche's Competitive Position In Hemophilia A

Nov 20 2017

Japan Nod Positive For Hemlibra But Shadows Linger

Mar 27 2018

Patient Death Casts Cloud Over Roche Emicizumab Hemophilia Trial

Feb 24 2017

Related Companies

Roche Holding AG

Takeda Pharmaceutical Co. Ltd.

Novo Nordisk A/S

Sanofi

Chugai Pharmaceutical Co., Ltd.

Additional Topics

Safety Risk Management Blood & Coagulation Disorders BioPharmaceutical

More from Drug Safety

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window